Henry McCusker

RegMed Investors

Recent Quotes

"A MESO licensee launched Temcell in Japan for treatment of aGVHD."

— Henry McCusker, RegMed Investors (2/25/16)
more >



Due to permission requirements, not all quotes are shown.